<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1d0c5e8c3">
    <name type="corporate">
         <namePart>United States Government Publishing Office</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
              <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
         <role>
              <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
              <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">author</roleTerm>
              <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
         <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
         <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
         <collectionCode>BILLS</collectionCode>
         <searchTitle>To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.;Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025;H.R. 1632 (IH)
    </searchTitle>
         <category>Bills and Statutes</category>
         <waisDatabaseName>119_cong_bills</waisDatabaseName>
         <branch>legislative</branch>
         <dateIngested>2025-03-18</dateIngested>
    </extension>
    <titleInfo>
         <title>To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>H.R. 1632 (IH)
    </title>
    </titleInfo>
    <originInfo>
         <publisher>U.S. Government Publishing Office</publisher>
         <dateIssued encoding="w3cdtf">2025-02-26</dateIssued>
         <issuance>monographic</issuance>
    </originInfo>
    <physicalDescription>
         <note type="source content type">deposited</note>
         <digitalOrigin>born digital</digitalOrigin>
         <extent>8 p.</extent>
    </physicalDescription>
    <classification authority="sudocs">Y 1.6:</classification>
    <classification authority="sudocs">Y 1.4/6:</classification>
    <identifier type="local">P0b002ee1d0c5e8c3</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/BILLS-119hr1632ih</identifier>
    <identifier type="preferred citation">H.R. 1632</identifier>
    <identifier type="stock number">021-610-00252-9</identifier>
    <identifier type="Parent ILS system id">000501532</identifier>
    <identifier type="Child ILS system id">000325573</identifier>
    <identifier type="Parent ILS title">Congressional bills</identifier>
    <identifier type="Child ILS title">House bills</identifier>
    <identifier type="former package identifier">f:h1632_ih.txt</identifier>
    <location>
         <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/BILLS-119hr1632ih</url>
         <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr1632ih/html/BILLS-119hr1632ih.htm</url>
         <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr1632ih/pdf/BILLS-119hr1632ih.pdf</url>
         <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr1632ih/xml/BILLS-119hr1632ih.xml</url>
    </location>
    <accessCondition type="GPO scope determination">fdlp</accessCondition>
    <recordInfo>
         <recordContentSource authority="marcorg">DGPO</recordContentSource>
         <recordCreationDate encoding="w3cdtf">2025-03-18</recordCreationDate>
         <recordChangeDate encoding="w3cdtf">2025-03-18</recordChangeDate>
         <recordIdentifier source="DGPO">BILLS-119hr1632ih</recordIdentifier>
         <recordOrigin>machine generated</recordOrigin>
         <languageOfCataloging>
              <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    <name type="personal">
         <namePart>Chip Roy</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm authority="marcrelator" type="text">sponsor</roleTerm>
              <roleTerm authority="marcrelator" type="code">spn</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on Energy and Commerce</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on Rules</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 5 Section 802</partNumber>
              <partNumber>Title 5 Section 802(b)(2)(A)</partNumber>
              <partNumber>Title 5 Section 802(e)(2)</partNumber>
        </titleInfo>
         <identifier type="USC citation">5 U.S.C. 802</identifier>
         <identifier type="USC citation">5 U.S.C. 802(b)(2)(A)</identifier>
         <identifier type="USC citation">5 U.S.C. 802(e)(2)</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 21 Section 360n-2</partNumber>
        </titleInfo>
         <identifier type="USC citation">21 U.S.C. 360n-2</identifier>
    </relatedItem>
    <extension>
         <docClass>hr</docClass>
         <accessId>BILLS-119hr1632ih</accessId>
         <congress>119</congress>
         <session>1</session>
         <originChamber>HOUSE</originChamber>
         <currentChamber>HOUSE</currentChamber>
         <billNumber>1632</billNumber>
         <billVersion reprint="false">ih</billVersion>
         <fileSuffix>ih</fileSuffix>
         <shortTitle type="measure">Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025</shortTitle>
         <officialTitle>To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.</officialTitle>
         <action date="2025-02-26">Mr. Roy introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action>
         <congCommittee authorityId="hsif00" chamber="H" congress="119" type="S">
                                
              <name type="authority-standard">Committee on Energy and Commerce</name>
                                
              <name type="authority-short">Energy and Commerce</name>
                            
        </congCommittee>
         <congCommittee authorityId="hsru00" chamber="H" congress="119" type="S">
                                
              <name type="authority-standard">Committee on Rules</name>
                                
              <name type="authority-short">Rules</name>
                            
        </congCommittee>
         <congMember bioGuideId="R000614" chamber="H" congress="119" party="R" role="SPONSOR" state="TX">
                                
              <name type="parsed">Mr. Roy</name>
                                
              <name type="authority-fnf">Chip Roy</name>
                                
              <name type="authority-lnf">Roy, Chip</name>
                            
        </congMember>
         <isPrivate>false</isPrivate>
         <isAppropriation>false</isAppropriation>
         <USCode title="5">
                                
              <section number="802"></section>
                                
              <section detail="(b)(2)(A)" number="802"></section>
                                
              <section detail="(e)(2)" number="802"></section>
                            
        </USCode>
         <USCode title="21">
                                
              <section number="360n-2"></section>
                            
        </USCode>
    </extension>
</mods>